English  |  正體中文  |  简体中文  |  Items with full text/Total items : 18055/20253 (89%)
Visitors : 24625264      Online Users : 609
RC Version 7.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
Scope Tips:
  • please add "double quotation mark" for query phrases to get precise results
  • please goto advance search for comprehansive author search
  • Adv. Search
    HomeLoginUploadHelpAboutAdminister Goto mobile version
    Please use this identifier to cite or link to this item: https://ir.cnu.edu.tw/handle/310902800/32598


    標題: High exposure to statins decrease the risk of new-onset dementia A nationwide population-based longitudinal cohort study
    作者: Chang, Chih-Feng
    Liou, Yi-Sheng
    Lin, Tsung-Kun
    Ma, Stacey
    Hu, Yu-Ru
    Chen, Hung-Yi
    Jong, Gwo-Ping
    貢獻者: Armed Force Taichung Gen Hosp, Div Cardiol, Dept Internal Med
    Natl Def Med Ctr
    Taichung Vet Gen Hosp, Dept Family Med
    Natl Def Med Ctr, Sch Publ Hlth
    Med Affairs Bur, Armed Forces Med Supplies Off
    Univ Calif San Diego, La Jolla
    Chia Nan Univ Pharm & Sci, Div Nutr
    China Med Univ, Inst Pharm
    Chung Shan Med Univ Hosp, Div Internal Cardiol
    Chung Shan Med Univ, 110,Sect 1,Chien Kuo N Rd
    關鍵字: high exposure to statins
    hyperlipidemia
    new-onset dementia
    日期: 2019-08
    上傳時間: 2020-07-29 13:51:27 (UTC+8)
    出版者: LIPPINCOTT WILLIAMS & WILKINS
    摘要: Several studies have shown that statin users have a lower risk of new-onset dementia (NOD) compared nonusers. However, other studies have shown opposite results. In this study, we investigated the association between the use of statins and the development of NOD. This was a longitudinal cohort study using data from claim forms submitted to the Taiwanese Bureau of National Health Insurance. The study included patients with NOD and non-NOD subjects from January 2002 to December 2013. We estimated the hazard ratios (HRs) of NOD associated with statin use, whereas nonuser subjects were used as a reference group. A total of 19,522 NOD cases were identified in 100,610 hyperlipidemic patients during the study period. The risk of NOD, after adjusting for sex, age, comorbidities, and concurrent medication, was lower among statin users than nonusers (HR 0.95, 95% CI [ confidence interval] 0.94-0.96; P<. 001). The adjusted HRs for NOD were 1.53 (95% CI, 1.45-1.62), 0.63 (95% CI, 0.57-0.71), and 0.34 (95% CI, 0.30-0.38) when the cumulative defined daily doses ranged from 28 to 365, 366 to 730, and more than 730 relative to nonusers, respectively. Weconcluded that statin use is associated with a decreasedNODrisk. The protective effect of statins forNODseemedto be related to high exposure to statins. This study also highlights that high exposure to statins has a dose-response effect on lowering NOD risk.
    關聯: Medicine, v.98, n.34, e16931
    Appears in Collections:[保健營養系(所) ] 期刊論文

    Files in This Item:

    File Description SizeFormat
    index.html0KbHTML1003View/Open


    All items in CNU IR are protected by copyright, with all rights reserved.


    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - Feedback